Tenaya Therapeutics, Inc. (TNYA)
↓ Download CSVKey ratios (FY2025)
-73.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$93.33M | -$115.95M | -$131.19M | -$125.62M | -$72.81M | -$38.91M | — |
| Net Income | -$90.60M | -$111.13M | -$124.08M | -$123.67M | -$72.72M | -$38.40M | — |
| EPS (Diluted) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | — | — |
| Total Assets | $146.92M | $119.94M | $170.51M | $278.94M | $314.19M | $148.16M | — |
| Total Liabilities | $23.66M | $27.09M | $31.09M | $35.57M | $35.66M | $8.72M | — |
| Shareholders' Equity | $123.27M | $92.85M | $139.42M | $243.38M | $278.53M | -$81.31M | -$43.74M |
| Cash & Equivalents | $100.55M | $4.32M | $45.68M | $95.27M | $38.13M | $128.53M | — |
| Operating Cash Flow | -$68.26M | -$90.50M | -$102.07M | -$104.42M | -$60.81M | -$35.45M | — |
| Capital Expenditures | $618.0K | $1.02M | $1.24M | $20.63M | $25.12M | $9.76M | — |
| Shares Outstanding | 216.76M | 86.54M | 68.33M | 66.86M | 41.29M | 1.21M | — |